LOW-VOLUME · PRURITUS
oritavancin Side Effects
oritavancin (also sold as Orbactiv) is a LOW-VOLUME FAERS extract #493 of 524 by FAERS report count. Still opens on PRURITUS: PRURITUS leads at 162 reports (18.1% of the book).
Data updated 2026-05-15
- 896
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
Among 896 FAERS reports for oritavancin, PRURITUS is the most-reported reaction (162). Volume band LOW-VOLUME #493 of 524 by FAERS report count.
Thinner FAERS extract for oritavancin (Orbactiv) (896 reports #493 of 524 by FAERS report count). PRURITUS leads at 162 reports (18.1% of the book). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2014–2025). Stamps SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
PRURITUS leads 162 of 896 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (180 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death appears on 30 reports (3.3% - MARKED). Reactions below co-occur in those rows only.
| Reaction | Reports |
|---|---|
| DEATH | 7 |
| CARDIAC ARREST | 5 |
| BACK PAIN | 4 |
| DYSPNOEA | 4 |
| NAUSEA | 4 |
| BLISTER | 3 |
| CHILLS | 3 |
| DRUG RESISTANCE | 3 |
| ACUTE KIDNEY INJURY | 2 |
| CARDIAC FAILURE CONGESTIVE | 2 |
| INFUSION RELATED REACTION | 2 |
| PRURITUS | 2 |
| SEPSIS | 2 |
| URTICARIA | 2 |
| VOMITING | 2 |
| ABDOMINAL PAIN | 1 |
| ACUTE MYELOID LEUKAEMIA | 1 |
| ACUTE MYOCARDIAL INFARCTION | 1 |
Reactions in Hospitalization Reports
Hospitalization mid-share (161, 18.0%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| CHILLS | 31 |
| DYSPNOEA | 29 |
| NAUSEA | 19 |
| BACK PAIN | 16 |
| CHEST PAIN | 15 |
| PYREXIA | 14 |
| VOMITING | 14 |
| INFUSION RELATED REACTION | 13 |
| AGRANULOCYTOSIS | 12 |
| TACHYCARDIA | 12 |
| PRURITUS | 10 |
| URTICARIA | 10 |
| ERYTHEMA | 9 |
| TREMOR | 9 |
| HYPOTENSION | 8 |
| MULTIPLE USE OF SINGLE-USE PRODUCT | 8 |
| RASH | 8 |
| DIZZINESS | 7 |
How to read oritavancin FAERS figures (SIGNAL · DEATH-MARKED · HOSP-MID)
FAERS holds 896 voluntary reports linked to oritavancin (Orbactiv), 2014-2025. Death is listed on 30 (3.3%). Hospitalization appears on 161 (18.0%). Top co-reported indication: Product Used For Unknown Indication.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with oritavancin
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-MARKED · HOSP-MID stamps.
ABS(total_reports) peer at 905 FAERS cases (Δ 9 heavier vs oritavancin); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 911 FAERS cases (Δ 15 heavier vs oritavancin); DEATH-MARKED · HOSP-MID · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 923 FAERS cases (Δ 27 heavier vs oritavancin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 863 FAERS cases (Δ 33 lighter vs oritavancin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 58.8 pp vs oritavancin's DEATH-MARKED): CASELOAD · HOSP-MID.
oritavancin stamps SIGNAL · SEX-BALANCED; class peers and methodology beat restating the same FAERS caveats on every effects URL.